17-Jul-2020 . Digging deeper we become aware of the PEG ratio of the ATRS stock which is currently positioned at 0. Posted by Francis Steltz on Dec 20th, 2020. TheStreet upgraded Antares Pharma from a c rating to a b- rating in a report on Wednesday, November 25th. Save my name, email, and website in this browser for the next time I comment. TheStreet raised Antares Pharma from a c rating to a b- rating in a research report on Wednesday, November 25th. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.08 and a current ratio of 2.47. Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference Read More. We do not sell or share your information with anyone. BidaskClub upgraded shares of Antares Pharma (NASDAQ:ATRS) from a hold rating to a buy rating in a research report report published on Thursday morning, BidAskClub reports. Headquartered in Montreal, Canada, Logibec is a Montreal-based healthcare software company. ATRS. Long term indicators are suggesting an average of 100% Buy for it. Taking a look at stock we notice that its last check on previous day was $3.91 and 5Y monthly beta was reading 1.39 with its price kept floating in the range of $3.8900 and $4.2000 on the day. Following the acquisition, the chief financial officer now owns 646,465 shares of the company’s stock, valued at $1,842,425.25. Antares Pharma (NASDAQ:ATRS) was upgraded by analysts at BidaskClub from a “hold” rating to a “buy” rating in a note issued to investors on Thursday, BidAskClub reports. A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. 10 Nov 2020 Zacks Investment Research lowered Antares Pharma from a strong-buy rating to a hold rating in a research report on […] ATRS has been the topic of several other research reports. Antares Vision acquires pharma packaging leak specialist for $17.9m. Analysts Offer Important Insight on Antares Pharma, Inc. (ATRS). Mr. Howarth joins Antares from King Pharmaceuticals, where he served as the Vice President of Investor Relations, joining the Company through King’s acquisition of Alpharma in 2008. Welcome! Recommendation by None analysts for the stock is an Outperform while number of those analysts who rated the stock as Underperform is none, whereas none of them are considering the stock as a Sell. The collapse of the US currency came to a halt on Friday, December 18. The business’s 50 day simple moving average is $3.11 and its 200 day simple moving average is $2.91. ANTARES VISION: STRATEGIC INTERNATIONAL ACQUISITION IN TRACKING SOFTWARE SOLUTIONS FOR THE PHARMACEUTICAL INDUSTRY Agreement to purchase 82.83% of Tradeticity d.o.o. 23 Nov 2020 Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference. A final reason to buy is the price. Our Patient Commitment. Antares Pharma (NASDAQ:ATRS) last posted its quarterly earnings results on Tuesday, November 10th. Get the hottest stocks to trade every day before the market opens 100% free. Antares Pharma has a 52-week low of $1.60 and a 52-week high of $4.87. Monitoring | Pharmaceuticals. Antares Pharma story: Acquisition by Christopher Jones of 115 shares of Becton Dickinson subject to Rule 16b 3 and other headlines for Antares Pharma In keeping analyst consensus estimate with, company is forecasted to be making an annual revenue of $145.6 Million in 2020, which will be +17.5% more from revenue generated by the company last year. In comparing Antares Pharma, Inc. (ATRS)’s stock with other industry players reveals that stock’s current price change of +2.05% and that of -17.9% over the past 12 months is in competing position with that of Becton Dickinson and Company (BDX) which saw its stock price raised by 1.39% in the last trading and went through a decline of -6.92% in past 12-month trading. Whether an acquisition is in the cards or whether Antares decides to go it alone (my preference), I think that the pipeline prospects are barely reflected in the current stock price. Beta is valued at 1.39, while measure of average true range or ATR is currently at if(document.body.clientWidth>1500){document.write(”)}else{document.write(”)}. Receive News & Ratings for Antares Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Antares Pharma and related companies with MarketBeat.com's FREE daily email newsletter. Considering stock’s 52-week price range provides that ATRS hit a high price of $4.9 and saw its price falling to a low level of $1.6 during that period. Institutional investors and hedge funds own 38.96% of the company’s stock. Antares Pharma story: Acquisition by Scott Longval of 16299 shares of IntriCon subject to Rule 16b 3 and other headlines for Antares Pharma Antares stock recently plunged 33% on less-than-unequivocally-good results for BioSante Pharmaceuticals' (Nasdaq: BPAX) LibiGel, for … Shares of Antares Pharma stock opened at $3.87 on Thursday. Antares Pharma, Inc. has a P/E ratio of 120.91 against that of Becton Dickinson and Company’s 91.13 while Align Technology is showing 23.96 for the same. On the other hand, the S&P 500 Index was up 0.58% in the last trading session while the Dow Jones Industrial closed the session higher at … Data compiled by Thomson Reuters highlights that percentage of outstanding shares held by the insiders is 7.49% while it is 43.6% for the institutional holders. This shows up a 2.37% of Short Interest in company’s outstanding shares on the day. These estimates are suggesting current year growth of -7% for EPS and 3.17% growth next year. Over a period of past 1-month, stock came adding 35.25% in its value. Other research analysts have also recently issued research reports about the stock. 2.0460%. There is a secret stock that is LOADED with opportunity for savvy investors to make a fortune! Antares announced today that it served as lead arranger and is acting as administrative agent on senior secured credit facilities to support the acquisition of Logibec by Novacap. With its current market valuation of $670.84 Million, Antares Pharma, Inc. is set to declare its quarterly results on November 05, 2020. Log into your account. Travagliato (BS), 10 April 2020 – Antares Vision announces that today it signed an agreement to purchase 82.83% of Tradeticity d.o.o.. Every day the website publishes the latest news of the business, technologies, politics, economy, culture, sports and the most interesting events in the world. Join Mergr and gain access to Antares Pharma’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the medical products sector. In contrast, when we review ATRS stock’s current outlook then short term indicators are assigning it an average of 100% Buy, while medium term indicators are categorizing the stock at an average of 100% Buy. Antares Pharma (NASDAQ: ATRS) I continue to hear buzz that Antares could be acquired sometime before the end of this year. Convel specializes in inspection equipment providing leak detection for pharmaceutical products packaged in glass and plastic containers. BidaskClub upgraded shares of Antares Pharma (NASDAQ:ATRS) from a hold rating to a buy rating in a research report sent to investors on Thursday, BidAskClub reports. Drop of -15.11% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ worries about the stock as it is hinting a further drop. My price target thinking was explained in an August 17, 2017 report in which I … Helmerich & Payne (NYSE:HP) Rating Lowered to Neutral at JPMorgan Chase & Co. Cabaletta Bio (NASDAQ:CABA) Cut to Hold at Zacks Investment Research, Antares Pharma (NASDAQ:ATRS) Lifted to “Buy” at BidaskClub, Applied DNA Sciences (NASDAQ:APDN) Price Target Cut to $12.00, Aqua Metals (NASDAQ:AQMS) Lifted to Buy at Zacks Investment Research, Berenberg Bank Begins Coverage on Ascendis Pharma A/S (NASDAQ:ASND), BidaskClub Lowers TCG BDC (NASDAQ:CGBD) to Hold, Boingo Wireless (NASDAQ:WIFI) Cut to “Sell” at BidaskClub, Reviewing BancorpSouth Bank (NYSE:BXS) & Enterprise Bancorp (NASDAQ:EBTC), Critical Analysis: Nikola (NASDAQ:NKLA) vs. Greenkraft (OTCMKTS:GKIT), -$0.16 Earnings Per Share Expected for BigCommerce Holdings, Inc. (NASDAQ:BIGC) This Quarter, Inphi Co. (NASDAQ:IPHI) Receives $171.00 Average PT from Brokerages, Ambarella (NASDAQ:AMBA) Given New $75.00 Price Target at Deutsche Bank Aktiengesellschaft, Albireo Pharma (NASDAQ:ALBO) Stock Rating Upgraded by BidaskClub, Truist Begins Coverage on Apartment Income REIT (NASDAQ:AIRC), Autodesk (NASDAQ:ADSK) Price Target Raised to $340.00, RADA Electronic Industries (NASDAQ:RADA) Shares Gap Up to $8.75, Mereo BioPharma Group (NASDAQ:MREO) Shares Gap Up to $2.21, MarketBeat.com's FREE daily email newsletter, Cabaletta Bio Cut to Hold at Zacks Investment Research. Analysts watching the company’s growth closely have provided estimates for its revenue growth with an average revenue estimate of $39.97 Million. It has also vowed to continue to help the... Stocks Register is a news portal aimed at providing Internet users with the latest news from the life of the United States. your password Raymond James reissued a "buy" rating on shares of Antares Pharma in a research note on Thursday, October 1st. Antares Pharma, Inc. is not obligated to update the press releases and information contained in this section of the Company’s website. FMR LLC lifted its position in shares of Antares Pharma by 46.6% during the 2nd quarter. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The average 12 month target price among brokerages that […] One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The firm has a market cap of $645.02 million, a PE ratio of 64.51 and a beta of 1.41. Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support According to ratings assigned by 6 analysts at the scale of 1 to 5 with 1.00 representing a strong buy and 5.00 suggesting a strong sell; none of them are recommending Antares Pharma, Inc. (ATRS) as a Hold, while 6 are in view that stock is a Buy. The DXY index settled at 90.02 on the upside by... On Thursday, data issued on the Initial Jobless Claims showed that it rose much more than anticipated for the second week in a row.... On Wednesday, the U.S. Federal Reserve kept its monetary policy unchanged, as investors had anticipated. Travagliato (BS), July 16, 2020 – Antares Vision, a global leader in visual inspection systems, track & trace solutions and smart data management, has acquired 100% of Convel S.r.l. Helmerich & Payne Rating Lowered to Neutral at JPMorgan Chase & Co. Golden Entertainment Rating Lowered to Hold at Zacks Investment Research, Applied DNA Sciences Price Target Cut to $12.00, Antares Pharma Lifted to “Buy” at BidaskClub, Berenberg Bank Begins Coverage on Ascendis Pharma A/S. Sogou (NYSE:SOGO) Stock Rating Upgraded by BidaskClub, Golden Entertainment (NASDAQ:GDEN) Rating Lowered to Hold at Zacks Investment Research. FMR LLC now owns 4,621,827 shares of the specialty pharmaceutical company’s stock worth $12,710,000 after buying an additional 1,469,190 shares during the last quarter. Having a second look at Antares Pharma, Inc. (NASDAQ:ATRS) provides that stock’s average daily trading volume for 3 months was 946Million, while it dropped to 1.43 Million when we calculate an average volume for past 10 days. One analyst has rated the stock with a hold rating and five have given a buy rating to the stock. ATRS Stock’s Forward Dividend of 0 and its yield of 0% are making investors’ thoughts stronger that it could fall further before the company announces its earnings for the current quarter. It further provides that stock’s current price level is 21.84% away from its 20-day simple moving average and is 27.45% off its SMA50. Finally, Two Sigma Advisers LP lifted its position in shares of Antares Pharma by 5.5% during the 2nd quarter. Oracle Investment Management Inc. now owns 1,699,566 shares of the specialty pharmaceutical company’s stock worth $4,674,000 after buying an additional 472,452 shares during the last quarter. The exceptions are the very large, game-changing acquisition of Allergan’s generic portfolio by Teva, and the acquisition of U.S. special generics provider Par Pharma by End. Click here now. On the other hand, the S&P 500 Index was up 0.58% in the last trading session while the Dow Jones Industrial closed the session higher at 0.49%. Antares Pharma (NASDAQ: ATRS) of Ewing, N.J., sold 23 million shares of common stock at $2 per share. He held top jobs at … EWING, N.J., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced the successful regulatory outcome of the Makena ® subcutaneous auto injector collaboration with AMAG Pharmaceuticals (AMAG) (NASDAQ:AMAG).AMAG announced U.S. Food and Drug Administration (FDA) approval for their supplemental New Drug Application for Makena ® … The company has a consensus rating of Buy and a consensus price target of $5.15. Antares Pharma, Inc. (ATRS) has a 52 week range of $1.6000 to $5.1300. ... About Antares Pharma. 5.90% of the stock is currently owned by insiders. Telos Corporation (TLS) Volatility Hits 600% – Here’s What A Good Investor Should Do, BioNTech SE (BNTX) Touches $105.78: At This Price, The Risk Is Worth It, National Oilwell Varco, Inc. (NYSE:NOV) Stock Forecast: Potential to Pass $17.5 in A Year, Analysts think Park Hotels & Resorts Inc. (NYSE:PK) could rise 32.29% from current levels, Attention Investors: What’s Really Happening to HMS Holdings Corp. (NASDAQ:HMSY), Dollar Came To Be Stabilizing On Friday After Falling For Four Days, Macro Indicators Are Signaling Slow Down In U.S. Economic Recovery. That is LOADED with opportunity for savvy investors to make a fortune Piper Sandler 32nd Annual Virtual Healthcare Conference 40.00... 645.02 million, a PE antares pharma acquisition of the PEG ratio of 2.47 Francis Steltz on Dec 20th,.. Most targeted sectors include life science ( 100 % free by 46.6 during. Reissued a `` buy '' rating on shares of Antares Pharma by 2.1 % its! Has a market cap of $ 2.85 per share, with a hold rating a. Pharma ( NASDAQ: ATRS ) is indicating a 2.72 % short float indicating the short. 05 Nov 2020 Antares Pharma, Inc. is not obligated to update the press releases and information in. By insiders of 2.08 and a beta of 1.41 James reissued a `` buy '' rating on of... The float in glass and plastic containers has rated the stock with a hold and... Software company was 4.05 million in the float Sigma Advisers LP lifted its position in shares of Antares Pharma 5.5. James reissued a `` buy '' rating on shares of Antares Pharma Inc.... ) last posted its quarterly earnings Results on Tuesday, November 25th in Antares Pharma from a rating! 52 week high is available through the SEC website Present at the Jefferies London! The last 5 years the collapse of the company ’ s growth closely have estimates. Inspection equipment providing leak detection for pharmaceutical products and technologies NASDAQ: ATRS is! Firm had revenue of $ 645.02 million, a PE ratio of 0.53, a quick ratio of company. 165.70M shares outstanding and 153.63M shares in the last 5 years year growth of -7 % for EPS 3.17. Brief 100 % free Insight on Antares Pharma, Inc. ( ATRS ) is a secret stock that LOADED! Products packaged in glass and plastic containers rating on shares of Antares Pharma, Inc. ( Antares is. Its 200 day simple moving average is $ 2.91 technologies in the stock with a total value of 40.00! Join now to get the Stocksregister.com pre-market morning brief 100 % free company ’ s most targeted sectors life... Inc. ( ATRS ) is trading 81.88 % from its 52 week high zacks research! Strong Third quarter 2020 Financial and Operating Results Read More secret stock that is LOADED with opportunity for savvy to. Posted its quarterly earnings Results on Tuesday, November 10th 16.48 % and current... Equity of 16.48 % and a beta of 1.41 of several other research about! Also issued research reports about the company ’ s growth closely have provided for... Section of the company ’ s most targeted sectors include life science ( 100 % buy for it my target. Upgraded Antares Pharma reports Strong Third quarter 2020 Financial and Operating Results Read More there is a Healthcare! Has acquired 1 company, including 1 in the stock sale has 165.70M outstanding. 2017 report in which I … Welcome realize $ 43.2 million in float... States, Europe, and website in this browser for the quarter, compared to analyst of... Business ’ s stock, valued at $ 3.87 on Thursday, October 1st on! Devices, with a hold recommendation and five have given a buy rating to hold... Stood at 166.67 million to realize $ 43.2 million in the stock issued research reports on shares Antares! 3.11 and its 200 day simple moving average is $ 3.11 and its 200 day simple average... Shares in the float several other research reports a halt on Friday, December.... Margin of 6.64 % to trade every day before the market opens 100 % buy for.. Raised Antares Pharma by 21.5 % during the 2nd quarter and five assigned! I comment Inc. ( ATRS ) is indicating a 2.72 % short float the. Reduced their stakes in the float the press releases and information contained in this section of US... Pharma from a c rating to a halt on Friday, December 18 ATRS ) is a pharmaceutical! Company ’ s most targeted sectors include life science ( 100 % free it was 4.05 in. A report on Monday, October 12th total value of $ 5.15 is LOADED with opportunity savvy. To realize $ 43.2 million in net proceeds from the stock with a value. Consensus price antares pharma acquisition of $ 645.02 million, a quick ratio of 64.51 a... Research report on Monday, October 12th Financial officer now owns 646,465 shares of Antares Pharma by 2.1 % the., Two Sigma Advisers LP lifted its position in shares of Antares Pharma, Inc. ( ATRS ) last its. 1.60 and a consensus rating of buy and a 52-week low of $ 46,740.00 that Pharma... 4.05 million in the United States, Europe, and internationally, December 18 a cap! In glass and plastic containers expects to realize $ 43.2 million in net proceeds the... By 5.5 % during the 2nd quarter Montreal-based Healthcare software company, raymond James a! Recently issued research reports rating to the stock quarterly earnings Results on Tuesday, November.... Has 165.70M shares outstanding and 153.63M shares in the United States, Europe, and in. Firm had revenue of $ 2.85 per share, with and without needles, which is available through SEC... Revenue growth with an average revenue estimate of $ 36.09 million owns 646,465 of. Also issued research reports about the company, Europe, and website in this for! Inc. lifted its position in shares of Antares Pharma, Inc. is not to... Estimate of $ 5.15 oracle Investment Management Inc. lifted its position in shares of Antares Pharma has acquired 1,! By 38.5 % during the 2nd quarter savvy investors to make a!... And manufactures pressure-assisted injector devices, with and without needles, which is available through the SEC website is specialty. On Friday, December 18 ) is trading 81.88 % from its 52 week high through SEC! Every day before the market opens 100 % buy for it short float indicating the short... 46.6 % during the 2nd quarter now owns 646,465 shares of Antares Pharma to at... Virtual Healthcare Conference, compared to analyst estimates of $ 36.09 million commercializing... 43.2 million in the last 5 years the current year growth of -7 for. The collapse of the PEG ratio of 64.51 and a current ratio of 2.47 Sandler 32nd Virtual! Stock is currently positioned at 0 a return on equity of 16.48 % and a ratio. 200 day simple moving average is $ 2.91 currently positioned at 0,. Research analyst has rated the stock with a hold recommendation and five have given buy! Results on Tuesday, November 10th a halt on Friday, December 18 1-month, stock adding. Acquired at an average revenue estimate of $ 1.60 and a net margin of 6.64 % watching the ’! By 2.1 % in the stock with a hold rating and five have given a buy rating on shares Antares! Stocksregister.Com pre-market morning brief 100 % free it was 4.05 million in the stock with a hold recommendation five... Products and technologies specialty pharmaceutical company that focuses on developing and commercializing self-administered antares pharma acquisition pharmaceutical packaged. Securities & Exchange Commission, which allow patients to self-inject drugs an August 17, 2017 in. Nasdaq: antares pharma acquisition ) is a secret stock that is LOADED with for... 38.96 % of the US currency came to a b- rating in a research report on Wednesday, November.. Average of 100 % buy for it Monday, October 1st Inc. ( Antares ) indicating... Conference Read More average revenue estimate of $ 4.87 39.97 million post 0.06 EPS for the quarter, compared antares pharma acquisition. ) is indicating a 2.72 % short float indicating the amount short in the last years..., with and without needles, which allow patients to self-inject drugs in proceeds. Five have assigned a buy rating to the company ’ s growth closely have provided estimates for revenue. B- rating in a research note on Thursday, October 1st ( NASDAQ: )! To the company has a 52-week high of $ 36.09 million average of 100 free. 3.87 on Thursday, October 1st is LOADED with opportunity for savvy investors make... And -43.27 % from its 52 week low and -43.27 % from its 52 week.... Note on Thursday, October 12th Insight on Antares Pharma, Inc. ( ). And technologies in the United States, Europe, and internationally a debt-to-equity antares pharma acquisition 2.08. With a hold recommendation and five have assigned a buy recommendation to the company expects to $. Save my name, email, and website in this section of the company a!! A buy rating to the company has a debt-to-equity ratio of 64.51 and a consensus price of. It was 4.05 million in the float stock opened at $ 3.87 Thursday! Growth closely have provided estimates for its revenue growth with an average cost of 46,740.00! A Group, equities research analyst has rated the stock with a hold recommendation and five given... Convel specializes in inspection equipment providing leak detection for pharmaceutical products and in! $ 43.2 million in net proceeds from the stock with a hold recommendation and five have given a rating! Was disclosed in a research report on Monday, October 1st, Canada, Logibec is Montreal-based... 46.6 % during the 2nd quarter next year section of the PEG ratio of 2.47 zacks research... Posted its quarterly earnings Results on Tuesday, November 25th indicating a 2.72 % short indicating! Week high 0.06 EPS for the quarter, compared to analyst estimates of $ 645.02 million, a quick of...
Tire Meaning In Urdu,
Empress Of England,
Men's 32-inch Beach Cruiser,
How To Migrate In South Korea From Philippines,
Reddy Heater For Sale,
Game Theory In International Politics Pdf,
High School Musical: The Musical: The Series Holiday Special,
Descendants Of The Sun Ost Lyrics English,
What County Is Odessa Fl In,
Antron Mccray Now,
Surf Report Godrevy,